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Abstract
Background: Genetic polymorphism is an inevitable component of a complex organism especially
in multistage infectious organisms such as malaria parasites. Understanding the population genetic
structure of the parasites would provide valuable information for effective malaria control
strategies. Recently, the development of molecular tools like PCR has made analysis of field samples
possible and easier and research on Plasmodium vivax has also been strengthened. Not many reports
are available on the genetic polymorphism of P. vivax from the Indian sub-continent. This study
evaluates the extent of diversity in field isolates of India with respect to Pvgam-1.
Methods: A study was designed to assess the diversity of Pvgam-1 among field isolates from India,
using a nested PCR assay. Field isolates were collected from different regions of the country and
the observed variability was confirmed by sequencing data.
Results: Both Belem and Chesson type alleles were present either exclusively or in mixed form
among isolates of all 10 study sites. The Belem type allele was predominant, occurring in 67% of
isolates. The proportion of isolates showing the mixed form (both Belem and Chesson type alleles
occurring together in the same isolate) was about 13 overall (up to 38.5% in some isolates).
Sequencing of the PCR-amplified Belem and Chesson type alleles confirmed the PCR results.
Among the 10 study sequences, 11 polymorphic sites and four singleton variations were observed.
All the nucleotide substitutions were non-synonymous.
Conclusion:  Study shows limited diversity of Pvgam-1  marker in Indian isolates with well
representation of both Belem and Chesson type alleles.
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Background
Plasmodium vivax is the most widespread human malaria
parasite and is responsible for 70–80 million cases annu-
ally [1]. In India, it is the most prevalent of human
malaria parasites, contributing 50–55% cases of malaria
each year. P. vivax infections are rarely fatal but impact
heavily on personal health placing a considerable eco-
nomic burden upon individuals and communities [2].
Malaria eradication programmes are facing a formidable
challenge due to the spread of drug resistance and the
complex population genetic structure of malaria parasites.
Genetic polymorphism is an inevitable component of a
complex organism, especially in multistage infectious
organisms such as malaria parasites. Understanding the
genetic population structure of the parasites may provide
valuable information for effective malaria control strate-
gies. There have been few studies on genetic polymor-
phism in P. vivax, first because more work has been done
on the more virulent human malaria parasite, Plasmodium
falciparum, and secondly because of the non-availability of
continuous  in-vitro  cultures for P. vivax. Recently, the
development of molecular tools, such as PCR, has made
analysis of field samples possible and easier, thus
strengthening research on P. vivax. The availability of the
P. vivax genome sequence in the public domain has fur-
ther facilitated this work.
P. vivax sub-populations have been reported between tem-
perate zone type (Belem strain) and tropical zone type
(Chesson strain) on the basis of different markers such as
18 S SSU rRNA [3], relapse pattern [4], and Pvcsp gene [5].
Markers used for exploring population genetic structure of
P. vivax are limited, namely the Pvmsp-1 [6], Pvmsp-3α [7],
Pvcsp [5], Pvdbp [8], Pvama1 [9], Pvgam-1 [10] and micro-
satellite markers [11]. Pvgam-1  is expressed during the
gametocyte stage and an antibody raised against the corre-
sponding antigen has been reported to completely block
the development of parasites in the mosquito midgut and
is reported as potential transmission blocking vaccine
candidate [12]. Polymorphism in the C-terminal part of
the gene was reported which is due to deletion of 33, 57
& 84 bp guanine-rich motif and is not covered by epitopic
region of the PvGAM-1 antigen [12]. However, the valida-
tion of Pvgam-1 as a genetic marker has been limited so far
[13,14]. This paper reports the prevalence of Chesson and
Belem type alleles in field isolates from India, on the basis
of PCR genotyping of Pvgam-1 in different epidemiologi-
cal regions.
Materials and methods
Study sites
A total of 252 field isolates were collected from 10 differ-
ent geographical regions where P. vivax is prevalent,
including coastal, mainland and Island regions of India
(Figure 1). Delhi, Gautam Budh Nagar (Uttar Pradesh),
Palamau (Jharkhand), Panna (Madhya Pradesh) and
Nadiad (Gujarat) are located in northern region of the
country and are under the influence of An. culicifacies vec-
tor. Transmission is mainly in post-monsoon months.
Both species of Plasmodia are present but predominance
is different. Except Delhi, in all other study sites, samples
were collected during malaria outbreaks. Sites in Gautam
Budh Nagar and Nadiad were in rural settings while
Panna and Palamau in tribal dominated forested ecotype.
Sundergarh district (Orissa) is hyper endemic for malaria
with more than 90% of the total malaria cases being that
of P. falciparum and P. vivax poorly reported. It is tribal
dominated area under the influence of highly anthro-
pophagic vector An. fluviatilis. Chennai (Tamil Nadu),
Goa and Navi Mumbai (Maharashtra) are coastal areas
with predominance of P. vivax. Chennai has a problem of
urban malaria with An. stephensi as a major vector, while
in Goa and Navi Mumbai both An. stephensi &An. culici-
facies are responsible for malaria transmissions. Car Nico-
bar island in Bay of Bengal is endemic for malaria with
perennial transmissions. Both the species i.e., P. vivax and
P. falciparum are prevalent throughout the year and An.
sundaicus is the vector.
Blood samples were collected during spot surveys or from
patients attending a clinic for malaria diagnosis at head-
quarters in Delhi or at field units, between 2000 and
2004. Microscopically diagnosed P. vivax-positive blood
was spotted on autoclaved Whatman filter paper (3 mm)
strips and dried blood spots were stored at 4°C. Blood
smears were stained with JSB stain [15] and examined at a
1,000 × magnification. The study protocol was approved
by the ethics committee of the National Institute of
Malaria Research, and all blood spots were collected with
the consent of the patients.
Genomic DNA extraction and PCR amplification
Genomic DNA was extracted from three punches of What-
man filter paper with blood spots using QIAamp mini
DNA kit (Cat. No.51306, Qiagen, Germany). DNA was
eluted in 100 μl sterile triple distilled water. Genomic
DNA was analysed using species-specific primers of Tira-
sophon [16] to confirm the P. vivax positivity in the sam-
ples. Only isolates having confirmed P. vivax infection by
PCR were included in the study. All amplification reac-
tions were carried out in a final volume of 20 μl, which
included 1 μl template genomic DNA in primary PCR and
0.5 μl of primary product as template in nested PCR. PCR
primers and the protocols used for amplification of
Pvgam-1 were those of Snewin et al [10].
Sequencing of PCR products
PCR products were purified from agarose gel by using gel
extraction kit (QIAquick, Cat. No. 28706). SequencingMalaria Journal 2006, 5:90 http://www.malariajournal.com/content/5/1/90
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was done by cycle sequencing method using Big Dye ter-
minator method with ready to use kit (3.1 version, Perkin
Elmer Corp) and run on the ABI Prism 310 automated
DNA sequencer. Each sample was sequenced by forward
and reverse primers to confirm deletion/point mutations
in the study fragment of Pvgam-1. Sequences were ana-
lysed using DNASTAR (Lasergene, USA) software. All
DNA sequences were aligned using ClustalW method.
Results
All the 252 isolates showed amplification and observed
fragments were 550 bp (Belem) and 520 bp (Chesson)
type alleles (Figure 2). These fragments were observed
exclusively as well as in combination with each other
among the isolates. Table 1 gives the data obtained on the
distribution of both Belem and Chesson type alleles
among the isolates of different regions. Data revealed that
Belem type allele (550 bp) was the predominant allele
and exclusively it has occurred in 41.5% to 95.0% of the
isolates in different study sites. Proportion of isolates
showing Chesson type allele exclusively was upto 61.5%.
A good proportion of isolates (13.09 %) showed mixed
infection of both the alleles and their proportion ranged
in different sites between zero to 38.5% (Table 1).
Map of India showing study sites Figure 1
Map of India showing study sitesMalaria Journal 2006, 5:90 http://www.malariajournal.com/content/5/1/90
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Our results are different to earlier observations made
among Korean and Thai isolates [13,14]. Korean isolates
had shown only Belem type allele while among Thai iso-
lates Chesson type was the predominant allele (92%).
Further, Imwong et al [13] observed PCR associated arti-
facts thus suggested Pvgam-1  not to be a dependable
marker. In the present study, PCR associated artifacts were
not observed in any of the isolates. Pvgam-1 is highly GC
rich and GC rich regions are reported to be highly prone
to illegitimate recombinations thus generating PCR arti-
facts [17].
PCR product from 10 randomly selected isolates (Chen-
nai-Ch 1,4,6 & 62; Delhi-D8; Navi Mumbai- NM1; Goa-
6210,7844,8055,9086) were sequenced. Sequencing of
the PCR amplified products confirmed the size variations.
Alignment of sequences with the reference sequence (Acc.
No. X84734) showed good identity and an identity of 85
to 100% was observed between the study isolates. In all
the four Chesson type isolates (NM1, 62, 6210, 9086)
complete deletion of 33 bp segment was confirmed by
sequence alignment. In a total of 10 sequences analyzed
in this study, 11 polymorphic sites and 4 singleton varia-
tions were observed (Figure 3). Further analysis revealed
that polymorphic sites were present only in Belem type
allele and not in Chesson type. In Belem type allele simi-
lar sequence variations were observed in the isolates of
Chennai, Delhi and Goa. All the nucleotide substitutions
were non-synonymous. Sequences have been submitted
to GenBank vide accession numbers DQ673860-69.
Discussion
Studies on genetic structure of P. vivax is limited mainly
because of non-availability of suitable polymorphic mark-
ers. Snewin et al [10], added gam-1 to the list of available
P. vivax markers namely csp, msp-1, msp-3α, dbp, ama-1 by
describing a polymorphic region in the gam-1  gene
(encoding a P. vivax transmission blocking candidate anti-
gen) and reported four variants based on nucleotide
sequence deletions among 10 Sri Lankan isolates. How-
ever, later monomorphic nature of gam-1 was observed
among Korean isolates [14]. On the other hand, among
Table 1: Distribution of Pvgam-1 alleles in Indian populations
Study Sites Number of samples tested Observed Allelic Composition of the isolates
Belem (550 bp) Chesson (520 bp) Belem + Chesson
Delhi 53 22 (41.5%) 16 (30.1%) 15 (28.3%)
Gautam Budh Nagar 8 6 (75%) 2 (25%) 0
Nadiad 50 37 (74%) 4 (8%) 9 (18%)
Navi Mumbai 8 6 (75%) 2 (25%) 0
Goa 36 24 (66.7%) 11 (30.5%) 1 (2.7%)
Chennai 35 31 (88.5%) 2 (5.7%) 2 (5.7%)
Panna 18 14 (77.8%) 4 (22.2%) 0
Palamu 11 10 (91%) 0 1 (9%)
Car Nicobar 20 19 (95%) 1 (5%) 0
Sundergarh 13 0 8 (61.5%) 5 (38.5%)
Total 252 169 (67.0%) 50(19.8%) 33(13.09%)
Agarose Gel electrophoretogramme showing allelic variations of Pvgam-1 Figure 2
Agarose Gel electrophoretogramme showing allelic variations of Pvgam-1. Belem type allele in lane 4, 5, 8, 10 & 11, Chesson 
type allele in lane 1 & 6 and both alleles in lane nos. 2, 3, 7 & 9. A 100 bp DNA ladder is used as a marker in lane 12
1         2           3         4        5            6   7         8         9           10        11
M
1         2           3         4        5            6   7         8         9           10        11
M
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Thai isolates, both Belem and Chesson type alleles were
observed with predominance (92%) of Chesson type
allele (520 bp) [13].
Our observations of presence of both Belem and Chesson
strains of P. vivax among Indian field isolates has been
similar to observations of another study reporting pres-
ence of the both the strains temperate (Belem) and tropi-
cal (Chesson) in Indian population based on the
relapsing pattern of vivax infection among the patient [4].
Though the present study could not correlate molecular
markers with clinical findings, but predominance of both
Belem and Chesson type allele was observed in all the
study sites and in isolates collected during spot surveys
from malaria endemic as well as during outbreaks.
The polymorphic region of Pvgam-1 analysed in this study
is known not to be covering the epitopic region responsi-
ble for transmission-blocking activity [10]. However, the
highly polymorphic nature of the C-terminal region of the
fragment in the Belem type allele (11 sites out of 15 show-
ing polymorphism) led to speculation that this region
may be under host immune pressure and may also be
involved in immunogenicity. In Chesson type alleles, no
variation was observed in this region and the deletion of
33 bp repeats may be disrupting the peptide sequence
required for antigenicity. This is supported by the con-
served nature of this region in all four Chesson type allele
(NM1, 62, 6210, 9086) sequenced in this study. Further
functional studies are needed to prove whether or not this
variable region is involved in immunogenicity.
The highly polymorphic nature of Indian P. vivax field iso-
lates had previously been recognized by the relapse pat-
tern [4], drug susceptibility [18] and enzymes
polymorphism [19,20]. Based on epidemiological fea-
tures, Adak et al [4] suggested the existence of polymor-
phic  P. vivax population in Delhi region of India and
populations were characterized by three types of incuba-
tion periods following primary attack of malaria. Short
term relapsing strains (Chesson) showed susceptibility to
Primaquine and Bulaquine (anti-relapse drugs) while
long term relapsing strains (temperate or St. Elizabeth)
were not susceptible to these drugs [18].
Studies using biochemical and molecular markers have
shown polymorphic forms of Glucose phosphate isomer-
ase (6 alleles), glutamate dehydrogenase (7 alleles) and
adenosine deaminase enzymes (5 alleles) [19] as well as
size & sequence variations in msp-3α, csp, gam-1 [20]. A
Pvgam-1 protein alignments showing amino acid variations Figure 3
Pvgam-1 protein alignments showing amino acid variations.
10 20 30 40 50 60 70 80 90100 110 120 130 140 150 160 170 180 190 200 210
VGTFRRYLQMVNAVLCEMKDYNVGRAINLIFSFVVNVFSKFYLTLHSGGDVGGGGDLLDGNFDGGGDRLI  1 mod std.seq
.......................................................-----------....  1 NM1.seq
.......................................................-----------....  1 62.seq
.......................................................-----------....  1 6210.seq
.....................................................................F  1 7844.seq
......................................................................  1 8055.seq
.......................................................-----------....  1 9086.seq
......................................................................  1 CH1.seq
.....................................................................F  1 CH4.seq
.....................................................................F  1 CH6.seq
......................................................................  1 D8.seq
220 230 240 250 260 270 280 290 300 310 320 330 340 350
GHFDEGGDLLVEHFLPAYILRGVLKIVFPFAPHIAEVLFIRLFRRVQK                        211 mod std.seq
................................................                        178 NM1.seq
................................................                        178 62.seq
................................................                        178 6210.seq
...HK....R......V.................GK.....F...G..                        211 7844.seq
.........R......V.................G......F.Q.GK.                        211 8055.seq
................................................                        178 9086.seq
...........................................Q....                        211 CH1.seq
...NK....R......V.F...............GK.....F.Q.GK.                        211 CH4.seq
...NK....R..N...V.................GK...F.F.Q.G..                        211 CH6.seq
................V.............P...GK.....F.Q.G..            211 D8.seqMalaria Journal 2006, 5:90 http://www.malariajournal.com/content/5/1/90
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recent study using csp, msp-1 and msp-3α in Kolkatta, east-
ern region, have also reported highly polymorphic nature
of Indian P. vivax isolates [21].
The present study is first to reveal dimorphic nature of
gam-1 in the field isolates studied from different parts of
India. Pvgam-1 marker having two alleles with good fre-
quency distribution among the isolates increases the
probability of identifying mixed infections. Studies
related to single nucleotide polymorphism, house keep-
ing genes, microsatellite markers as well as drug resistance
associated mutations, identification of single clone infec-
tion is a prerequisite. Thus, present study suggested
Pvgam-1 marker could be a useful marker for the identifi-
cation of multiple infections of different genotypes in
addition to Pvmsp-1, Pvcsp &Pvmsp-3α. Advantage of
Pvgam-1 marker is that its analysis is performed by means
of simple PCR assays and does not require sequencing,
hybridization or RFLP analysis as do other markers genes
such as csp or msp-3α locus.
Conclusion
Data obtained in this study shows limited diversity of
Pvgam-1 marker in Indian isolates with well representa-
tion of both Belem and Chesson type alleles.
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